Gefitinib in heavily pretreated non small cell lung cancer: Results of the expanded access program in Eastern France.

被引：0
|
作者：
Spaeth, D
Deplanque, G
Favrot, N
Paillot, N
Lang, MP
Cuguiliere, A
Seigneur, J
机构：
[1] Ctr Alexis Vautrin, Nancy, France
[2] Dept Oncol, Scy Chazelles, France
[3] Ctr GF Leclerc, Dijon, France
[4] Serv Pneumol, Metz, France
[5] Serv Pneumol, Mt St Martin, France
[6] HIA Legouest, Metz, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7323
引用
收藏
页码：696S / 696S
页数：1
相关论文
共 50 条
  • [41] Gefitinib therapy for non-small cell lung cancer
    Birnbaum A.
    Ready N.
    Current Treatment Options in Oncology, 2005, 6 (1) : 75 - 81
  • [42] Gefitinib for the treatment of non-small-cell lung cancer
    Hida, Toyoaki
    Ogawa, Shizu
    Park, Jang Chul
    Park, Ji Young
    Shimizu, Junichi
    Horio, Yoshitsugu
    Yoshida, Kimihide
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (01) : 17 - 35
  • [43] Spotlight on gefitinib in non-small-cell lung cancer
    Frampton, JE
    Easthope, SE
    AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (02) : 133 - 136
  • [44] Gefitinib for advanced non-small cell lung cancer
    Sim, Esther H. A.
    Yang, Ian A.
    Wood-Baker, Richard
    Bowman, Rayleen V.
    Fong, Kwun M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (01):
  • [45] Lorlatinib in pretreated ALK/ROS1-positive non-small cell lung cancer (NSCLC): Results from the German early access program
    Frost, N.
    Christopoulos, P.
    Kauffmann-Guerrero, D.
    Stratmann, J. A.
    Riedel, R.
    Schaefer, M.
    Alt, J.
    Guetz, S.
    Brinkmann, J.
    Griesinger, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S874 - S874
  • [46] Gefitinib in advanced non-small cell lung cancer
    Sharma, R
    Boyer, M
    Clarke, S
    Millward, M
    INTERNAL MEDICINE JOURNAL, 2005, 35 (02) : 77 - 82
  • [47] Pemetrexed in heavily pretreated non-small-cell lung cancer patients: case report and review of the literature
    Tartarone, Alfredo
    FUTURE ONCOLOGY, 2010, 6 (12) : 1937 - 1940
  • [48] Gefitinib for non-small-cell lung cancer treatment
    D'Incecco, Armida
    Cappuzzo, Federico
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (06) : 987 - 996
  • [49] Gefitinib: Phase II and III results in advanced non-small cell lung cancer
    Kelly, K
    Averbuch, S
    SEMINARS IN ONCOLOGY, 2004, 31 (01) : 93 - 99
  • [50] Retrospective analysis of patients with advanced non-small cell lung cancer who participated in the extended access program (EAP) of gefitinib
    Kang, J. -H.
    Kang, S. Y.
    Kim, H. T.
    Lee, J. S.
    Shim, B. Y.
    Park, B. -B.
    Park, J. O.
    Park, K.
    Shin, S. W.
    Heo, D. S.
    Kim, D. -W.
    Ryoo, B. -Y.
    Lee, J. C.
    Na, I. I.
    Kim, S. -W.
    Suh, C.
    Cho, B. C.
    LUNG CANCER, 2006, 52 : S23 - S24
12345